In mice bearing subcutaneous MCF7-Y537S mutant ERα+ breast cancer model, [18F]-FLT effectively measures proliferation changes after the administration of the CDK 4/6 palbociclib inhibitor alone or in combination with SAR439859. The gene discussed is ESR1; the disease is breast carcinoma.